Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBV Vaccine Model for HIV Vaccine Trials in Drug Users
NCT00841477Phase 3Completed
- Sponsor
- National Institute on Drug Abuse
- Start
- Jan 2004
- Primary completion
- Jun 2007
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of Hepatitis B vaccine in hepatitis B (HBV) (4 arms), sponsored by National Institute on Drug Abuse. Primary endpoint: Compliance (adherence) for 3 doses hepatitis vaccination at 2 years. Started Jan 2004; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00841477.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00841477.